Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
9h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
10h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
12h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
19h agoBuffalo Potash Files Annual Information Form and New Technical Report
20h agoIonik Announces 30-Day Extension of Senior Debt Facility
Ernexa Therapeutics Inc. logo

Ernexa Therapeutics Inc.

About

11.99USD-0.47 -3.77%
Closed • Updated at 23:30 GMT+00:00
Market Cap$13.98M
Volume83.9K
Beta2.47
RSI62.93
Health TechnologyPharmaceuticals: Major

Ernexa Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 20 2026
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
May 6 2026
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
Apr 30 2026
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
Feb 20 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Feb 6 2026
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

Community Chat

Ask AI

Try asking
6ix6ix